Steven J. Roy
Directeur Général chez VetDC, Inc.
Profil
Steven J.
Roy is currently the President, Chief Executive Officer & Director at VetDC, Inc. Prior to this, he worked as the Director-Licensing & Alliance Management at Amgen, Inc. from 1994 to 2007 and as a Laboratory Supervisor at Ligand Pharmaceuticals, Inc. from 1988 to 1992.
He received his undergraduate degree from the University of California San Diego and his MBA from the University of Michigan.
Postes actifs de Steven J. Roy
Sociétés | Poste | Début |
---|---|---|
VetDC, Inc.
VetDC, Inc. Agricultural Commodities/MillingProcess Industries VetDC, Inc. develops cancer drugs for pets. It is a cancer-focused veterinary biopharmaceutical company developing innovative, underutilized human technologies for use in companion animals. It offers VDC-1101, a novel anti-cancer pro-drug from Gilead Sciences for use in animal cancer. The company was founded by Terry J. Opgenorth in 2009 and is headquartered in Fort Collins, CO. | Directeur Général | 01/01/2010 |
Anciens postes connus de Steven J. Roy
Sociétés | Poste | Fin |
---|---|---|
AMGEN INC. | Corporate Officer/Principal | - |
LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
Formation de Steven J. Roy
University of California San Diego | Undergraduate Degree |
University of Michigan | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
AMGEN INC. | Health Technology |
LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
Entreprise privées | 1 |
---|---|
VetDC, Inc.
VetDC, Inc. Agricultural Commodities/MillingProcess Industries VetDC, Inc. develops cancer drugs for pets. It is a cancer-focused veterinary biopharmaceutical company developing innovative, underutilized human technologies for use in companion animals. It offers VDC-1101, a novel anti-cancer pro-drug from Gilead Sciences for use in animal cancer. The company was founded by Terry J. Opgenorth in 2009 and is headquartered in Fort Collins, CO. | Process Industries |